# JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)

> **NCT04084223** · NA · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 51 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** Ultrasound

## Key facts

- **NCT ID:** NCT04084223
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-10
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-24
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Slower pace of enrollments
- **Last updated:** 2025-01-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04084223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04084223, "JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04084223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*